StockNews.com began coverage on shares of Issuer Direct (NYSE:ISDR – Free Report) in a report issued on Wednesday morning. The firm issued a hold rating on the stock.
Issuer Direct Stock Performance
ISDR opened at $10.00 on Wednesday. The company’s 50 day moving average is $10.34 and its 200 day moving average is $9.72. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.37. The company has a market cap of $38.30 million, a price-to-earnings ratio of -28.57 and a beta of 0.77. Issuer Direct has a 12-month low of $7.61 and a 12-month high of $19.03.
Institutional Investors Weigh In On Issuer Direct
An institutional investor recently raised its position in Issuer Direct stock. Bard Associates Inc. raised its stake in shares of Issuer Direct Co. (NYSE:ISDR – Free Report) by 14.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 133,805 shares of the company’s stock after purchasing an additional 16,620 shares during the period. Bard Associates Inc. owned 3.49% of Issuer Direct worth $1,599,000 as of its most recent SEC filing. 50.02% of the stock is currently owned by hedge funds and other institutional investors.
About Issuer Direct
Issuer Direct Corporation operates as a communications and compliance company, provides solutions for both public relations and investor relations professionals in the United States and internationally. The company provides press release distribution, media databases, media monitoring, and newsrooms through media advantage platform; ACCESSWIRE, a news dissemination and media outreach service; and Webcaster Platform, a cloud-based webcast, webinar, and virtual meeting platform that delivers live and on-demand streaming of events to audiences of various sizes, as well as allows customers to create, produce, and deliver events.
See Also
- Five stocks we like better than Issuer Direct
- What is a Special Dividend?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is a Stock Market Index and How Do You Use Them?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Issuer Direct Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Issuer Direct and related companies with MarketBeat.com's FREE daily email newsletter.